“…FMRP is an mRNA-binding protein that regulates mRNA stability and translation for a number of synaptic and cytoskeleton-associated proteins (Castets et al, 2005;Lu et al, 2004;Muddashetty et al, 2007;Reeve et al, 2005;Todd et al, 2003;Zalfa et al, 2007;Zhang et al, 2001). FMRP function regulates the activity-dependent control of synaptic connections via intersection with group 1 metabotropic glutamate receptor (mGluR) signaling (Antar et al, 2004;Bear et al, 2004;Ferrari et al, 2007;Huber et al, 2002;Nosyreva and Huber, 2006;Pan and Broadie, 2007;Pan et al, 2008). The synapsopathic clinical manifestations of the disease include mild to severe mental retardation (Penagarikano et al, 2007), delayed and depressed developmental trajectories (Bailey et al, 2001a;Bailey et al, 2001b), deficits in short-term memory (Cornish et al, 2001;Munir et al, 2000), hyperactivity (Einfeld et al, 1991), disordered sleep (Gould et al, 2000), seizures (Sabaratnam et al, 2001), and the cytological presentation of long, immature-looking cortical dendritic spines, indicating inappropriate development and/or failure of pruning and synapse elimination (Hinton et al, 1991;Rudelli et al, 1985).…”